文献速递前列腺癌

转移性前列腺癌患者根治性前列腺切除术中淋巴结清扫的效果:生存与早期术后结局的当代分析

The Effect of Lymph Node Dissection in Metastatic Prostate Cancer Patients Treated with Radical Prostatectomy: A Contemporary Analysis of Survival and Early Postoperative Outcomes.
PubMed 文献 · Eur Urol Oncol · 2018-11-22

基于SEER数据库(2004-2014)330例和NIS数据库(2004-2013)1663例接受根治性前列腺切除术的转移性前列腺癌患者,比较淋巴结清扫与未清扫的结局。SEER分析中淋巴结清扫与更低的肿瘤特异性死亡(HR 0.52)和总死亡(HR 0.38)相关;NIS分析中淋巴结清扫与更高的输血率相关(OR 1.54),总体并发症和住院时长无差异。

要点

  • SEER数据库中330例转移性前列腺癌根治术患者,199例(60.3%)接受淋巴结清扫。
  • 淋巴结清扫与更低的肿瘤特异性死亡(HR 0.52)和总死亡(HR 0.38)相关。
  • NIS数据库中淋巴结清扫与更高输血率相关(OR 1.54),总体并发症无差异。

核心结论

  • 首次证明在转移性前列腺癌中,根治性前列腺切除术时行淋巴结清扫与更低的肿瘤特异性死亡和总死亡相关,但不增加围手术期并发症率。

研究设计与样本

  • 基于SEER数据库(2004-2014)和NIS数据库(2004-2013)接受根治性前列腺切除术的转移性前列腺癌患者。
  • SEER分析采用逆概率治疗加权(IPTW)后的Kaplan-Meier曲线和多变量Cox回归模型。
  • NIS分析采用IPTW和聚类调整后的多变量逻辑回归及多变量泊松回归模型。

临床怎么用

  • 作者认为,淋巴结清扫可能进一步改善转移性前列腺癌患者根治性前列腺切除术的生存获益。
  • 作者建议,在转移性前列腺癌中应强烈考虑根治性前列腺切除术时行淋巴结清扫。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

BACKGROUND: Radical prostatectomy (RP) may occasionally be performed in patients with metastatic prostate cancer (mPCa). However, the role of lymph node dissection (LND) for such cases is unknown. OBJECTIVE: To test the contemporary effect of LND at RP on cancer-specific mortality (CSM), overall mortality (OM), and early postoperative outcomes compared with no LND in mPCa patients. DESIGN, SETTING, AND PARTICIPANTS: We identified surgically treated mPCa patients within the Surveillance, Epidemiology, and End Result (SEER) database (2004-2014) and the Nationwide Inpatient Sample (NIS) database (2004-2013). OUTCOME MEASUREMENTS AND STATISTICAL ANALYSIS: In the SEER-based analyses, Kaplan-Meier plots and multivariable Cox regression models (CRMs) were used after inverse probability of treatment weighting (IPTW) adjustment. In the NIS-based analyses, multivariable logistic regression (MLR) and multivariable Poisson regression (MPR) models were used after IPTW and adjustment for clustering. RESULTS AND LIMITATIONS: Within the SEER database, 199 (60.3%) of 330 mPCa patients treated with RP underwent LND. After IPTW, multivariable CRMs showed lower CSM (hazard ratio [HR]: 0.52, confidence interval [CI]: 0.31-0.87; p=0.01) and OM (HR: 0.38, CI: 0.24-0.60; p<0.001) rates after LND at RP in patients. Within the NIS database, 1186 (71.3%) of 1663 mPCa patients treated with RP underwent LND. After IPTW, MLR models showed higher rates of transfusions (odds ratio [OR]: 1.54, CI: 1.03-2.30; p=0.03) after LND versus no LND. No difference was observed in overall complications (OR: 1.04, CI: 0.77-1.41, p=0.7). In MPR, LND at RP did not affect the length of stay (OR: 1.05, CI: 0.97-1.14, p=0.2). CONCLUSIONS: We are the first to demonstrate that LND at RP is associated with lower CSM and OM in the setting of mPCa, but not with higher rates of perioperative complications. PATIENT SUMMARY: Lymph node dissection might further improve the survival benefit of radical prostatectomy in metastatic prostate cancer patients. In consequence, lymph node dissection at radical prostatectomy should strongly be considered in the metastatic setting.

来源:Eur Urol Oncol,查看原文。版权归原作者所有。

引用

  1. Mazzone E, Preisser F, Nazzani S, et al. The Effect of Lymph Node Dissection in Metastatic Prostate Cancer Patients Treated with Radical Prostatectomy: A Contemporary Analysis of Survival and Early Postoperative Outcomes. Eur Urol Oncol. 2018. PMID: 31411992. doi:10.1016/j.euo.2018.10.010

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。